Significant emphasis has been placed recently on designing more effective fluorouracil (5-FU)-based combination protocols for gastrointestinal cancer. Promising results were seen with 5-FU/leucovorin in combination with
Udo Vanhoefer, MD
Advertisement
Articles by Udo Vanhoefer, MD
Advertisement
Latest Updated Articles
- Oral Fluoropyrimidine-Based Combination Therapy in Gastrointestinal Cancer
Published: January 2nd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?
2
FDA Approves Liso-Cel in Marginal Zone Lymphoma After 2 Lines of Therapy
3
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
4
Silevertinib Displays Robust Antitumor Activity in EGFR-Mutated NSCLC
5
